HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshiyuki Kawashima Selected Research

Postgastrectomy Syndromes

5/2021Comparison of effects of six main gastrectomy procedures on patients' quality of life assessed by Postgastrectomy Syndrome Assessment Scale-45.
10/2015Optimal Roux-en-Y reconstruction after distal gastrectomy for early gastric cancer as assessed using the newly developed PGSAS-45 scale.
1/2015Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients.
6/2014Postgastrectomy Syndrome Assessment Scale (PGSAS)-45 and changes in body weight are useful tools for evaluation of reconstruction methods following distal gastrectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshiyuki Kawashima Research Topics

Disease

13Neoplasms (Cancer)
05/2022 - 07/2004
13Stomach Neoplasms (Stomach Cancer)
05/2022 - 01/2002
9Neoplasm Metastasis (Metastasis)
05/2022 - 08/2003
4Postgastrectomy Syndromes
05/2021 - 06/2014
4Sensorineural Hearing Loss
06/2010 - 03/2004
3Body Weight (Weight, Body)
05/2022 - 06/2014
3Hearing Loss (Hearing Impairment)
12/2017 - 09/2010
3Colorectal Neoplasms (Colorectal Cancer)
11/2014 - 08/2003
2Lymphatic Metastasis
08/2021 - 03/2017
2Weight Loss (Weight Reduction)
05/2021 - 10/2016
2Vasculitis (Vasculitides)
12/2020 - 02/2016
2Rectal Neoplasms (Rectal Cancer)
12/2018 - 11/2014
2Colonic Neoplasms (Colon Cancer)
02/2018 - 08/2003
2Hepatocellular Carcinoma (Hepatoma)
11/2013 - 11/2010
2Thrombosis (Thrombus)
11/2010 - 07/2004
1Biliary Tract Neoplasms (Biliary Tract Cancer)
07/2022
1Pancreatic Neoplasms (Pancreatic Cancer)
04/2022
1Osteonecrosis (Kienbock's Disease)
12/2021
1Neurilemmoma (Schwannoma)
12/2021
1Hernia (Hernias)
12/2021
1Osteoporosis
12/2021
1Mucinous Adenocarcinoma (Mucinous Carcinoma)
09/2021
1Carcinoma (Carcinomatosis)
08/2021
1Esophageal Neoplasms (Esophageal Cancer)
01/2020
1Nasal Polyps (Nasal Polyp)
11/2019
1Rhinosinusitis
11/2019
1Fever (Fevers)
10/2019
1Sarcoma (Soft Tissue Sarcoma)
10/2019
1Leukocytosis (Pleocytosis)
10/2019
1Fistula
12/2018
1Splenic Infarction
09/2018
1Cryopyrin-Associated Periodic Syndromes
12/2017
1Inflammation (Inflammations)
12/2017
1Nonsyndromic Deafness
12/2017
1Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2017
1Multiple Endocrine Neoplasia Type 1
11/2017
1Hyponatremia
03/2017
1Leukopenia
03/2017
1Neutropenia
03/2017
1Sigmoid Neoplasms
11/2016
1Infections
11/2016
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
02/2016
1Microscopic Polyangiitis
02/2016
1Churg-Strauss Syndrome (Allergic Angiitis)
02/2016
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
02/2016
1Otitis Media
02/2016
1Thromboembolism
11/2015
1Colic (Abdominal Cramps)
11/2015
1Bile Duct Neoplasms (Bile Duct Cancer)
11/2014
1Type 1 Spherocytosis
11/2014
1Pancytopenia
11/2013
1Disease Progression
11/2013

Drug/Important Bio-Agent (IBA)

3Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2019 - 11/2013
3Leucovorin (Folinic Acid)FDA Link
12/2018 - 08/2003
2Cisplatin (Platino)FDA LinkGeneric
07/2022 - 03/2017
2Eicosapentaenoic AcidIBA
05/2022 - 01/2019
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
12/2020 - 02/2016
2Capecitabine (Xeloda)FDA Link
02/2019 - 03/2017
2Fluorouracil (Carac)FDA LinkGeneric
12/2018 - 08/2003
2Mitomycin (Mitomycin-C)FDA LinkGeneric
11/2011 - 11/2010
2NucleotidesIBA
09/2009 - 08/2005
2Proteins (Proteins, Gene)FDA Link
08/2005 - 08/2003
1GemcitabineFDA Link
07/2022
1Diphosphonates (Bisphosphonates)IBA
12/2021
1GadoliniumIBA
12/2021
1Monoclonal AntibodiesIBA
12/2021
1DenosumabFDA Link
12/2021
1Mucin 5ACIBA
11/2019
1C-Reactive ProteinIBA
10/2019
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2019
1Bevacizumab (Avastin)FDA Link
12/2018
1InflammasomesIBA
12/2017
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
12/2017
1XELOXIBA
03/2017
1Docetaxel (Taxotere)FDA Link
03/2017
1Anti-Bacterial Agents (Antibiotics)IBA
11/2016

Therapy/Procedure

14Gastrectomy
05/2022 - 11/2011
7Therapeutics
02/2019 - 08/2003
5Adjuvant Chemotherapy
04/2022 - 11/2013
5Drug Therapy (Chemotherapy)
12/2018 - 11/2013
5Hepatectomy
11/2016 - 11/2010
4Lymph Node Excision (Lymph Node Dissection)
04/2022 - 11/2015
3Colectomy
02/2018 - 11/2012
2Pancreatectomy
04/2022 - 11/2012
2Pancreaticoduodenectomy
09/2021 - 11/2014
2Splenectomy
11/2014 - 11/2013
1Combination Drug Therapy (Combination Chemotherapy)
07/2022
1Neoadjuvant Therapy
05/2022
1Radiotherapy
12/2021
1Aftercare (After-Treatment)
08/2021
1Neck Dissection (Radical Neck Dissection)
08/2021
1Postoperative Care
05/2021
1Operative Surgical Procedures
05/2021
1Esophagectomy
01/2020
1Ligation
11/2015
1Sutures (Suture)
11/2014
1Cholecystectomy
11/2014
1Molecular Targeted Therapy
11/2012
1Nephrectomy
11/2012
1Mastectomy (Mammectomy)
11/2012